David Kirn sold $1.2M of 4D Molecular Therapeutics (FDMT)

Executed Jun 22, disclosed Jun 23, 1 day later.

Value, as filed

$1.2M

114,746 sh × $10.47

Executed

Jun 22

the trade date, as filed

Disclosed

Jun 23

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DK David Kirn See Remarks profile →

David Kirn (See Remarks) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales, 1 filed past the two-business-day deadline), most often in 4D Molecular Therapeutics, Inc. (FDMT). The largest single filing was $1.2M of FDMT (114,746 sh × $10.47, as filed), executed Jun 22.

The name

FDMT 4D Molecular Therapeutics, Inc. FDMT · Healthcare · 7 filings in 24 months ticker →

Healthcare · 4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by David Kirn in FDMT

FDMTSALE 4D Molecular Therapeutics, Inc. $811K
58,333 sh × $13.90
Exec Sep 14
Filed Sep 16 · 5:13 PM ET FDMTSALE 4D Molecular Therapeutics, Inc. $1.1M
69,076 sh across 2 lots
Exec Aug 19
Filed Aug 21 · 4:06 PM ET FDMTSALE 4D Molecular Therapeutics, Inc. $275K
26,842 sh × $10.23
Exec Aug 4
Filed Aug 5 · 4:10 PM ET FDMTSALE 4D Molecular Therapeutics, Inc. $125K
12,415 sh × $10.05
Exec Aug 3
Filed Aug 4 · 4:45 PM ET FDMTSALE 4D Molecular Therapeutics, Inc. $732K
57,891 sh across 2 lots
Exec Jul 9
Filed Jul 14 · 5:04 PM ET †